Syed Muhammad Adnan Ali
6PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 16, 2024
Significant Association of PD-L1 With CD44 Expression and Patient Survival: Avenues for Immunotherapy and Cancer Stem Cells Downregulation in Pancreatic Cancers.Saleema Mehboob Ali, Yumna Adnan, Zubair Ahmad
|Sep 06, 2022
Immunohistochemical analysis of a panel of cancer stem cell markers and potential therapeutic markers in pancreatic ductal adenocarcinoma.S M Adnan Ali, Yumna Adnan, Saleema Mehboob Ali
|Aug 29, 2022
Immunohistochemical Detection and Prognostic Significance of p53, Epidermal Growth Factor Receptor, Murine Double Minute 2, and Isocitrate Dehydrogenase 1 in Glioblastoma Multiforme Patients of Pakistan.Syed Muhammad Adnan Ali, Muhammad Shahzad Shamim, Syed Ather Enam
|May 11, 2022
Hormone receptors AR, ER, PR and growth factor receptor Her-2 expression in oral squamous cell carcinoma: Correlation with overall survival, disease-free survival and 10-year survival in a high-risk population.Yumna Adnan, Syed Muhammad Adnan Ali, Muhammad Sohail Awan
|Mar 28, 2022
Body Mass Index and Diabetes Mellitus May Predict Poorer Overall Survival of Oral Squamous Cell Carcinoma Patients: A Retrospective Cohort From a Tertiary-Care Centre of a Resource-Limited Country.Yumna Adnan, Syed Muhammad Adnan Ali, Muhammad Sohail Awan
|Mar 17, 2022
High CD44 Immunoexpression Correlates with Poor Overall Survival: Assessing the Role of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma Patients from the High-Risk Population of Pakistan.Yumna Adnan, S M Adnan Ali, Hasnain A Farooqui
Pageof 1
